Novelion Therapeutics Inc. announced that Mark Corrigan, M.D. has been appointed as Executive Chair of the Board of Directors. As Executive Chair, Dr. Corrigan will serve in a supervisory role to the Company's management team and will continue to perform the traditional duties of Board Chair. In connection with Dr. Corrigan's appointment, the Office of the CEO, which was comprised of Dr. Corrigan, Chief Operating Officer Jeff Hackman and former Chair Jason Aryeh, will be disbanded.

As interim CEO, Mr. Hackman will lead the company's operations, reporting into the Board. Chief Operating Officer Jeff Hackman appointed as Interim Chief Executive Officer (CEO).